BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Swanepoel T, Möller M, Harvey BH. N-acetyl cysteine reverses bio-behavioural changes induced by prenatal inflammation, adolescent methamphetamine exposure and combined challenges. Psychopharmacology 2018;235:351-68. [DOI: 10.1007/s00213-017-4776-5] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 5.2] [Reference Citation Analysis]
Number Citing Articles
1 Mncube K, Harvey B. Bio-behavioural changes in treatment-resistant socially isolated FSL rats show variable or improved response to combined fluoxetine-olanzapine versus olanzapine treatment. IBRO Neuroscience Reports 2022;13:284-298. [DOI: 10.1016/j.ibneur.2022.08.009] [Reference Citation Analysis]
2 Bühner LM, Kapanaiah SKT, Kätzel D. Chronic N-acetylcysteine treatment improves anhedonia and cognition in a mouse model of the schizophrenia prodrome. Front Behav Neurosci 2022;16:1002223. [DOI: 10.3389/fnbeh.2022.1002223] [Reference Citation Analysis]
3 Ni P, Ma Y, Chung S. Mitochondrial dysfunction in psychiatric disorders. Schizophr Res 2022:S0920-9964(22)00333-4. [PMID: 36175250 DOI: 10.1016/j.schres.2022.08.027] [Reference Citation Analysis]
4 Gyllenhammer LE, Rasmussen JM, Bertele N, Halbing A, Entringer S, Wadhwa PD, Buss C. Maternal Inflammation During Pregnancy and Offspring Brain Development: The Role of Mitochondria. Biological Psychiatry: Cognitive Neuroscience and Neuroimaging 2022;7:498-509. [DOI: 10.1016/j.bpsc.2021.11.003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
5 Guerrin CGJ, Shoji A, Doorduin J, de Vries EFJ. Immune Activation in Pregnant Rats Affects Brain Glucose Consumption, Anxiety-like Behaviour and Recognition Memory in their Male Offspring. Mol Imaging Biol 2022. [PMID: 35380336 DOI: 10.1007/s11307-022-01723-3] [Reference Citation Analysis]
6 Perez FA, Blythe S, Wouldes T, McNamara K, Black KI, Oei JL. Prenatal methamphetamine-impact on the mother and child-a review. Addiction 2022;117:250-60. [PMID: 33830539 DOI: 10.1111/add.15509] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
7 Mncube K, Möller M, Harvey BH. Post-weaning Social Isolated Flinders Sensitive Line Rats Display Bio-Behavioural Manifestations Resistant to Fluoxetine: A Model of Treatment-Resistant Depression. Front Psychiatry 2021;12:688150. [PMID: 34867504 DOI: 10.3389/fpsyt.2021.688150] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Petty A, Howes O, Eyles D. Animal models of relevance to the schizophrenia prodrome. Biological Psychiatry Global Open Science 2021. [DOI: 10.1016/j.bpsgos.2021.12.001] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
9 Guerrin CGJ, Doorduin J, Sommer IE, de Vries EFJ. The dual hit hypothesis of schizophrenia: Evidence from animal models. Neurosci Biobehav Rev 2021;131:1150-68. [PMID: 34715148 DOI: 10.1016/j.neubiorev.2021.10.025] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
10 Palaniyappan L, Park MTM, Jeon P, Limongi R, Yang K, Sawa A, Théberge J. Is There a Glutathione Centered Redox Dysregulation Subtype of Schizophrenia? Antioxidants (Basel) 2021;10:1703. [PMID: 34829575 DOI: 10.3390/antiox10111703] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 7.0] [Reference Citation Analysis]
11 MacDowell KS, Munarriz-Cuezva E, Meana JJ, Leza JC, Ortega JE. Paliperidone Reversion of Maternal Immune Activation-Induced Changes on Brain Serotonin and Kynurenine Pathways. Front Pharmacol 2021;12:682602. [PMID: 34054556 DOI: 10.3389/fphar.2021.682602] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
12 Smaga I, Frankowska M, Filip M. N-acetylcysteine as a new prominent approach for treating psychiatric disorders. Br J Pharmacol 2021;178:2569-94. [PMID: 33760228 DOI: 10.1111/bph.15456] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 12.0] [Reference Citation Analysis]
13 Caruso G, Grasso M, Fidilio A, Tascedda F, Drago F, Caraci F. Antioxidant Properties of Second-Generation Antipsychotics: Focus on Microglia. Pharmaceuticals (Basel) 2020;13:E457. [PMID: 33322693 DOI: 10.3390/ph13120457] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 7.5] [Reference Citation Analysis]
14 Blum K, Cadet JL, Gold MS. Psychostimulant use disorder emphasizing methamphetamine and the opioid -dopamine connection: Digging out of a hypodopaminergic ditch. J Neurol Sci 2021;420:117252. [PMID: 33279726 DOI: 10.1016/j.jns.2020.117252] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
15 Berríos-Cárcamo P, Quezada M, Quintanilla ME, Morales P, Ezquer M, Herrera-Marschitz M, Israel Y, Ezquer F. Oxidative Stress and Neuroinflammation as a Pivot in Drug Abuse. A Focus on the Therapeutic Potential of Antioxidant and Anti-Inflammatory Agents and Biomolecules. Antioxidants (Basel) 2020;9:E830. [PMID: 32899889 DOI: 10.3390/antiox9090830] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 8.0] [Reference Citation Analysis]
16 Westbrook SR, Carrica LK, Banks A, Gulley JM. AMPed-up adolescents: The role of age in the abuse of amphetamines and its consequences on cognition and prefrontal cortex development. Pharmacol Biochem Behav 2020;198:173016. [PMID: 32828971 DOI: 10.1016/j.pbb.2020.173016] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
17 Ni P, Chung S. Mitochondrial Dysfunction in Schizophrenia. Bioessays 2020;42:e1900202. [PMID: 32338416 DOI: 10.1002/bies.201900202] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 9.0] [Reference Citation Analysis]
18 Perkins DO, Jeffries CD, Do KQ. Potential Roles of Redox Dysregulation in the Development of Schizophrenia. Biol Psychiatry 2020;88:326-36. [PMID: 32560962 DOI: 10.1016/j.biopsych.2020.03.016] [Cited by in Crossref: 40] [Cited by in F6Publishing: 43] [Article Influence: 20.0] [Reference Citation Analysis]
19 Lotter J, Möller M, Dean O, Berk M, Harvey BH. Studies on Haloperidol and Adjunctive α-Mangostin or Raw Garcinia mangostana Linn Pericarp on Bio-Behavioral Markers in an Immune-Inflammatory Model of Schizophrenia in Male Rats. Front Psychiatry 2020;11:121. [PMID: 32296347 DOI: 10.3389/fpsyt.2020.00121] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
20 Rossetti AC, Paladini MS, Riva MA, Molteni R. Oxidation-reduction mechanisms in psychiatric disorders: A novel target for pharmacological intervention. Pharmacol Ther 2020;210:107520. [PMID: 32165136 DOI: 10.1016/j.pharmthera.2020.107520] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 12.5] [Reference Citation Analysis]
21 Demin KA, Lakstygal AM, Volgin AD, de Abreu MS, Genario R, Alpyshov ET, Serikuly N, Wang D, Wang J, Yan D, Wang M, Yang L, Hu G, Bytov M, Zabegalov KN, Zhdanov A, Harvey BH, Costa F, Rosemberg DB, Leonard BE, Fontana BD, Cleal M, Parker MO, Wang J, Song C, Amstislavskaya TG, Kalueff AV. Cross-species Analyses of Intra-species Behavioral Differences in Mammals and Fish. Neuroscience 2020;429:33-45. [DOI: 10.1016/j.neuroscience.2019.12.035] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
22 Capellán R, Moreno-Fernández M, Orihuel J, Roura-Martínez D, Ucha M, Ambrosio E, Higuera-Matas A. Ex vivo 1H-MRS brain metabolic profiling in a two-hit model of neurodevelopmental disorders: Prenatal immune activation and peripubertal stress. Schizophr Res 2019:S0920-9964(19)30505-5. [PMID: 31787482 DOI: 10.1016/j.schres.2019.11.007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
23 Schiavone S, Neri M, Harvey BH. Pathological Consequences of Drug Abuse: Implication of Redox Imbalance. Oxid Med Cell Longev 2019;2019:4780852. [PMID: 31915508 DOI: 10.1155/2019/4780852] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
24 Capellán R, Moreno M, Orihuel J, Roura-martínez D, Ucha M, Ambrosio E, Higuera-matas A. Ex vivo 1H-MRS brain metabolic profiling in a two-hit model of schizophrenia-related alterations: effects of prenatal immune activation and peripubertal stress.. [DOI: 10.1101/641761] [Reference Citation Analysis]
25 Cattane N, Richetto J, Cattaneo A. Prenatal exposure to environmental insults and enhanced risk of developing Schizophrenia and Autism Spectrum Disorder: focus on biological pathways and epigenetic mechanisms. Neurosci Biobehav Rev 2020;117:253-78. [PMID: 29981347 DOI: 10.1016/j.neubiorev.2018.07.001] [Cited by in Crossref: 53] [Cited by in F6Publishing: 44] [Article Influence: 13.3] [Reference Citation Analysis]
26 Berk M, Loo C, Davey CG, Harvey BH. Ketamine and rapidly acting antidepressants: Breaking the speed of sound or light? Aust N Z J Psychiatry 2018;52:1026-9. [DOI: 10.1177/0004867418783567] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
27 Schiavone S, Trabace L. The use of antioxidant compounds in the treatment of first psychotic episode: Highlights from preclinical studies. CNS Neurosci Ther 2018;24:465-72. [PMID: 29542255 DOI: 10.1111/cns.12847] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]